⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Humana's (HUM) Alliances To Offer Relief To Members With CKD

Published 12/11/2019, 10:33 PM
Updated 07/09/2023, 06:31 AM
HUM
-
SEM
-
GENN
-
WCG
-

Humana Inc. (NYSE:HUM) entered into agreements with Monogram Health and Somatus to boost its care management portfolio. The two specialized care management companies would help Humana provide customized services to its Humana Medicare Advantage and Commercial members, who suffer kidney disease and reside in four states. While Monogram Health operates in Louisiana and Mississippi, Somatus is located in Georgia and Virginia.

This unique tie-up would allow Humana to diagnose and manage kidney disease much better, which in turn, will likely improve overall health outcomes and quality of life. Many Americans suffer kidney diseases and with proper intervention, the same can be controlled. Chronic kidney disease (CKD) is the nation’s ninth-leading cause for death. Per Centers for Disease Control, CKD impacts more than 30 million Americans.

Humana expects to serve members with this condition and provide them with coordinated care to cure the same. Patients would also be given access to tools that would help in managing their health. The members would be able to get care within the comforts of their own homes. The services would also be delivered to members with chronic kidney and end-stage renal disease.

Teams from both companies include clinicians, such as nephrologists, nurses, dietitians and social workers. The range of services would consist of care coordination with an individual’s primary care physician and nephrologist, in-house health and medication evaluation, patient education about treatment choices as well as counselling sessions. Services through Monogram Health are already available while those via Somatus will commence on Jan 1, 2020.

This comprehensive approach to healthcare is in line with the company’s commitment to improve health outcomes through high quality care while keeping costs under control.

Humana has constantly taken up initiatives to boost its network and offer value-based customized care options. As of Sep 30, 2019, it had more than 2.3 million individual Medicare Advantage members and approximately 115,000 commercial members.

Shares of this Zacks Rank #3 (Hold) company have gained 10.3% in a year’s time, outperforming its industry’s 2.4% growth.



Stocks to Consider

Investors interested in the medical sector might consider some better-ranked stocks like Select Medical Holdings Corporation (NYSE:SEM) , WellCare Health Plans, Inc. (NYSE:WCG) and Genesis Healthcare, Inc. (NYSE:GEN) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Select Medical Holdings operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics and occupational health centers. In the trailing four quarters, the company’s average beat was 11.07%. The stock sports a Zacks Rank #1.

WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 17.32% in the preceding four quarters. It carries a Zacks Rank #2 (Buy).

Genesis Healthcare operates skilled nursing facilities and assisted/senior living facilities. In the last four quarters, the company delivered average beat of 80.96%. It has a Zacks Rank of 1.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Select Medical Holdings Corporation (SEM): Free Stock Analysis Report

WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

Genesis Healthcare, Inc. (GEN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.